Lack of interaction between α2-adrenoceptors and dopamine D2-receptors in mediating their inhibitory effects on [3H]dopamine release from rat nucleus accumbens slices
dc.contributor.author | Russell V.A. | |
dc.contributor.author | Lamm M.C.L. | |
dc.contributor.author | Taljaard J.J.F. | |
dc.date.accessioned | 2011-05-15T16:17:26Z | |
dc.date.available | 2011-05-15T16:17:26Z | |
dc.date.issued | 1993 | |
dc.description.abstract | The α2-adrenoceptor agonist, UK14304, dose-dependently inhibited the electrically stimulated release of dopamine (DA) from rat nucleus accumbens slices. This effect was antagonized by idazoxan, confirming that it was an α2-adrenoceptor mediated effect. There was no evidence of endogenous activation of noradrenergic receptors suggesting that the α2-adrenoceptor agonist was not acting presynaptically to inhibit noradrenaline release. An in vitro superfusion technique was used to investigate whether there was any interaction between α2-adrenoceptors and DA D2-receptors in mediating their inhibitory effects on [3H]DA release from rat nucleus accumbens slices. α2-Adrenoceptors and DA D2-receptors interact with similar second messenger systems and it was considered that they may compete for a common pool of G-proteins. The inhibitory effects of the α2-adrenoceptor agonist, UK14304, and the DA receptor agonists, quinpirole, apomorphine and pergolide were not independent. However, there was no evidence of any interaction between UK14304 and the DA D2-receptor antagonists, sulpiride or haloperidol, suggesting that the two receptors do not compete for a common pool of G-proteins in mediating their inhibitory effects on DA release. | |
dc.description.version | Article | |
dc.identifier.citation | Neurochemical Research | |
dc.identifier.citation | 18 | |
dc.identifier.citation | 3 | |
dc.identifier.issn | 03643190 | |
dc.identifier.other | 10.1007/BF00969084 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/14218 | |
dc.subject | alpha 2 adrenergic receptor | |
dc.subject | apomorphine | |
dc.subject | brimonidine | |
dc.subject | citalopram | |
dc.subject | desipramine | |
dc.subject | dopamine | |
dc.subject | dopamine 2 receptor | |
dc.subject | dopamine receptor blocking agent | |
dc.subject | dopamine receptor stimulating agent | |
dc.subject | guanine nucleotide binding protein | |
dc.subject | haloperidol | |
dc.subject | idazoxan | |
dc.subject | pergolide | |
dc.subject | quinpirole | |
dc.subject | sulpiride | |
dc.subject | tritium | |
dc.subject | animal tissue | |
dc.subject | article | |
dc.subject | brain slice | |
dc.subject | depression | |
dc.subject | dopamine release | |
dc.subject | male | |
dc.subject | nonhuman | |
dc.subject | nucleus accumbens | |
dc.subject | priority journal | |
dc.subject | rat | |
dc.subject | signal transduction | |
dc.subject | tissue perfusion | |
dc.subject | Adrenergic alpha-Agonists | |
dc.subject | Animal | |
dc.subject | Apomorphine | |
dc.subject | Binding, Competitive | |
dc.subject | Dopamine | |
dc.subject | Electric Stimulation | |
dc.subject | Ergolines | |
dc.subject | GTP-Binding Proteins | |
dc.subject | Haloperidol | |
dc.subject | In Vitro | |
dc.subject | Male | |
dc.subject | Nucleus Accumbens | |
dc.subject | Pergolide | |
dc.subject | Quinoxalines | |
dc.subject | Quinpirole | |
dc.subject | Rats | |
dc.subject | Rats, Wistar | |
dc.subject | Receptors, Adrenergic, alpha | |
dc.subject | Receptors, Dopamine D2 | |
dc.subject | Signal Transduction | |
dc.subject | Sulpiride | |
dc.subject | Support, Non-U.S. Gov't | |
dc.title | Lack of interaction between α2-adrenoceptors and dopamine D2-receptors in mediating their inhibitory effects on [3H]dopamine release from rat nucleus accumbens slices | |
dc.type | Article |